When Grants End, So Do Scientific Breakthroughs
New analysis from amfAR’s Public Policy Office assesses the human cost of terminated federal research grants focused on cancer.
September 22, 2025
By August 2025, thousands of active NIH research grants focused on leading health concerns for Americans have been terminated. This includes grants focused on prevention, care, and treatment of cancers and cancer-causing viruses like human papillomavirus (HPV). These grants had already been awarded to leading scientists and institutions across the U.S. to advance both basic science approaches to finding new therapies and applied science to bring those therapies to scale.
Terminating grants midstream puts at risk millions of dollars in research funds already invested. It means studies not completed, discoveries not made, and new treatments that will never reach patients.

Share This: